The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(4-(4-chlorophenyl)thiazol-2-yl)-1-(2-ethylphenyl)-6-(2-methylprop-1-enyl)-5-(piperazine-1-carbonyl)pyridin-2(1H)-one ID: ALA4878829
PubChem CID: 137548878
Max Phase: Preclinical
Molecular Formula: C31H31ClN4O2S
Molecular Weight: 559.13
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCc1ccccc1-n1c(C=C(C)C)c(C(=O)N2CCNCC2)cc(-c2nc(-c3ccc(Cl)cc3)cs2)c1=O
Standard InChI: InChI=1S/C31H31ClN4O2S/c1-4-21-7-5-6-8-27(21)36-28(17-20(2)3)24(30(37)35-15-13-33-14-16-35)18-25(31(36)38)29-34-26(19-39-29)22-9-11-23(32)12-10-22/h5-12,17-19,33H,4,13-16H2,1-3H3
Standard InChI Key: BBFBYFJYUHDKCB-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
16.8748 -12.3832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8748 -13.2082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5854 -13.6161 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.2988 -13.2082 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2988 -12.3832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5869 -11.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0128 -13.6217 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.1610 -13.6217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1592 -11.9728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1568 -11.1478 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4459 -12.3874 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.6066 -14.4400 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9015 -14.8706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9228 -15.6945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6484 -16.0889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3540 -15.6534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3293 -14.8309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0132 -11.9698 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.7659 -12.3075 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.3197 -11.6960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9092 -10.9802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1019 -11.1495 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
21.1356 -11.7849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4682 -12.5412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2876 -12.6300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7753 -11.9636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4378 -11.2061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6194 -11.1208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.5957 -12.0511 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.3582 -13.4040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1470 -12.6065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7731 -13.9856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8752 -10.7359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.8748 -9.9145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1610 -9.5002 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4459 -9.9136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4447 -10.7413 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1768 -14.4762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4731 -14.9065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
4 7 2 0
2 8 1 0
1 9 1 0
9 10 1 0
9 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
3 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 1 0
5 18 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
20 23 1 0
26 29 1 0
8 30 2 0
30 31 1 0
30 32 1 0
10 33 1 0
10 37 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 37 1 0
13 38 1 0
38 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 559.13Molecular Weight (Monoisotopic): 558.1856AlogP: 6.31#Rotatable Bonds: 6Polar Surface Area: 67.23Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 7.82CX LogP: 5.94CX LogD: 5.38Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.30Np Likeness Score: -1.15
References 1. Rohde JM, Karavadhi S, Pragani R, Liu L, Fang Y, Zhang W, McIver A, Zheng H, Liu Q, Davis MI, Urban DJ, Lee TD, Cheff DM, Hollingshead M, Henderson MJ, Martinez NJ, Brimacombe KR, Yasgar A, Zhao W, Klumpp-Thomas C, Michael S, Covey J, Moore WJ, Stott GM, Li Z, Simeonov A, Jadhav A, Frye S, Hall MD, Shen M, Wang X, Patnaik S, Boxer MB.. (2021) Discovery and Optimization of 2H -1λ2 -Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer., 64 (8.0): [PMID:33822623 ] [10.1021/acs.jmedchem.1c00019 ]